Mohammed Amin KHAN,Bryan Edward Jones,John Mcneill McGill
申请号：
US14603239
公开号：
US20150202296A1
申请日:
2015.01.22
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The invention relates to formulations that demonstrate the feasibility of oral absorption comprising glucose-like peptide-1 compounds and specified delivery agents, and to methods of stimulating GLP-1 receptor in a subject in need of such stimulation, by administration of the formulation of the present invention.
